Shares of Stoke Therapeutics sank Tuesday as the drugmaker said its CEO Dr. Edward Kaye is stepping down from his role.

One of the biggest Stoke City stories on transfer deadline day last month was the interest and subsequent offer for Wouter Burger. To be fair, you could say the bet365 jury is still out on the 24 ...

Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing ...

Stoke City have sacked manager Narcis Pelach. Pelach lasted just 19 games before being shown the door on Friday. Potters sporting director Jon Walters accepted responsibility for the appointment ...

Stoke Therapeutics' chief executive, Edward Kaye, is stepping down after more than seven years at the helm of the biotechnology company. Stoke on Tuesday said Ian Smith, a board member since ...

Stoke Therapeutics (STOK) announced that Edward Kaye has decided to step down from his role as CEO effective as of March 19. To facilitate a smooth transition, Kaye will serve as an advisor to the ...

Stoke Therapeutics shares fell Tuesday after the company announced the resignation of its CEO. Dr. Edward Kaye is stepping down from the position Wednesday, with the company beginning a search ...